Wir sind für Sie da!

Bei Fragen zu unseren Therapiegebieten, Produkten oder anderen Anliegen können Sie sich gerne persönlich mit uns in Verbindung setzen.

Kontaktieren Sie uns
Quellen
  1. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 The Lancet, 2025; 406, 1873-1922.
  2. WHO. Fact sheet: Chronic obstructive pulmonary disease (COPD). Stand: 10.06.2026. Online verfügbar unter: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Letzter Zugriff: 30.06.2026.
  3. Tian J, et al. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023 Mar;82(3):351-356.
  4. Stummvoll G. The patients’ perspective: living with lupus in Austria. Wien Klin Wochenschr. 2017;129:593-597. doi:10.1007/s00508-017-1175-1.
  5. Ruberg FL, et al. Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73:2872-91.
  6. Rubin J, Maurer MS. Cardiac amyloidosis: Overlooked, underappreciated, and treatable. Annu Rev Med. 2020;71:203-219.
  7. Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022 Apr;12(1):7-11.
  8. Foreman KJ, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052-2090.
  9. Vos T, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-1259.
  10. Savarese G, et al. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022;118(17):3272-3287.
  11. Ruze R, et al. Obesity and Type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Front End. 2023;14:1161521.
  12. Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 May;71(3):209-249.
  13. International Agency for Research on Cancer (IARC). Bladder cancer. Online abrufbar unter: https://www.iarc.who.int/cancer-type/bladder-cancer/. Letzter Zugriff: 12.03.2026.
  14. Statistik Austria. Krebserkrankungen (2026). Abrufbar unter: https://www.statistik.at/statistiken/bevoelkerung-und-soziales/gesundheit/krebserkrankungen. Letzter Zugriff: 20.02.2026.
  15. Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-263.
  16. Doubeni CA, et al. Diagnosis and Management of Ovarian Cancer. Am Fam Physician. 2016 Jun 1;93(11):937-944.
  17. Statistik Austria. Krebserkrankungen in Österreich 2024. Online verfügbar unter: https://www.statistik.at/fileadmin/publications/Krebs-2024_Webversion-barrierefrei.pdf. Letzter Zugriff: 12.03.2026.
  18. Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today (version 1.1). Lyon, France: International Agency for Research on Cancer; 2024. Online verfügbar unter: https://gco.iarc.who.int/today. Letzter Zugriff: 20.02.2026.

AT-16998 05/2026